سوق أدوات جمع العينات العالمية - اتجاهات الصناعة وتوقعاتها حتى عام 2030

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL SPECIMEN COLLECTION KIT MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATION

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE GLOBAL SPECIMEN COLLECTION KIT MARKET SIZE

2.2.1 VENDOR POSITIONING GRID

2.2.2 TECHNOLOGY LIFE LINE CURVE

2.2.3 TRIPOD DATA VALIDATION MODEL

2.2.4 MARKET GUIDE

2.2.5 MULTIVARIATE MODELLING

2.2.6 TOP TO BOTTOM ANALYSIS

2.2.7 CHALLENGE MATRIX

2.2.8 APPLICATION COVERAGE GRID

2.2.9 STANDARDS OF MEASUREMENT

2.2.10 VENDOR SHARE ANALYSIS

2.2.11 EPIDEMIOLOGY

2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS

2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 GLOBAL SPECIMEN COLLECTION KIT MARKET : RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 EPIDEMIOLOGY

7 INDUSTRY INSIGHTS

8 REGULATORY SCENARIO

9 GLOBAL SPECIMEN COLLECTION KIT MARKET , BY PRODUCT TYPE

9.1 OVERVIEW

9.2 BLOOD COLLECTION KITS

9.2.1 BLOOD COLLECTION TUBES

9.2.1.1. SERUM TUBES

9.2.1.1.1. GLASS

9.2.1.1.1.1 MARKET VALUE (USD MILLION)

9.2.1.1.1.2 MARKET VOLUME(UNITS)

9.2.1.1.1.3 AVEARGE SELLING PRICE(ASP)

9.2.1.1.2. PLASTIC

9.2.1.1.2.1 MARKET VALUE (USD MILLION)

9.2.1.1.2.2 MARKET VOLUME(UNITS)

9.2.1.1.2.3 AVEARGE SELLING PRICE(ASP)

9.2.1.1.3. OTHERS

9.2.1.2. PLASMA/WHOLE BLOOD TUBES

9.2.1.2.1. EDTA TUBES

9.2.1.2.1.1 GLASS

9.2.1.2.1.1.1. MARKET VALUE (USD MILLION)

9.2.1.2.1.1.2. MARKET VOLUME(UNITS)

9.2.1.2.1.1.3. AVEARGE SELLING PRICE(ASP)

9.2.1.2.1.2 PLASTIC

9.2.1.2.1.2.1. MARKET VALUE (USD MILLION)

9.2.1.2.1.2.2. MARKET VOLUME(UNITS)

9.2.1.2.1.2.3. AVEARGE SELLING PRICE(ASP)

9.2.1.2.2. LITHIUM HEPARIN TUBES

9.2.1.2.2.1 GLASS

9.2.1.2.2.1.1. MARKET VALUE (USD MILLION)

9.2.1.2.2.1.2. MARKET VOLUME(UNITS)

9.2.1.2.2.1.3. AVEARGE SELLING PRICE(ASP)

9.2.1.2.2.2 PLASTIC

9.2.1.2.2.2.1. MARKET VALUE (USD MILLION)

9.2.1.2.2.2.2. MARKET VOLUME(UNITS)

9.2.1.2.2.2.3. AVEARGE SELLING PRICE(ASP)

 

9.2.1.2.3. SODIUM HEPARIN TUBES

9.2.1.2.3.1 GLASS

9.2.1.2.3.1.1. MARKET VALUE (USD MILLION)

9.2.1.2.3.1.2. MARKET VOLUME(UNITS)

9.2.1.2.3.1.3. AVEARGE SELLING PRICE(ASP)

9.2.1.2.3.2 PLASTIC

9.2.1.2.3.2.1. MARKET VALUE (USD MILLION)

9.2.1.2.3.2.2. MARKET VOLUME(UNITS)

9.2.1.2.3.2.3. AVEARGE SELLING PRICE(ASP)

9.2.1.2.4. OTHERS

9.2.1.3. GLUCOSE TUBES

9.2.1.3.1. SODIUM FLUORIDE

9.2.1.3.1.1 PLASTIC

9.2.1.3.1.1.1. MARKET VALUE (USD MILLION)

9.2.1.3.1.1.2. MARKET VOLUME(UNITS)

9.2.1.3.1.1.3. AVEARGE SELLING PRICE(ASP)

9.2.1.3.1.2 GLASS

9.2.1.3.1.2.1. MARKET VALUE (USD MILLION)

9.2.1.3.1.2.2. MARKET VOLUME(UNITS)

9.2.1.3.1.2.3. AVEARGE SELLING PRICE(ASP)

9.2.1.3.2. POTASSIUM FLUORIDE

9.2.1.3.2.1 PLASTIC

9.2.1.3.2.1.1. MARKET VALUE (USD MILLION)

9.2.1.3.2.1.2. MARKET VOLUME(UNITS)

9.2.1.3.2.1.3. AVEARGE SELLING PRICE(ASP)

9.2.1.3.2.2 GLASS

9.2.1.3.2.2.1. MARKET VALUE (USD MILLION)

9.2.1.3.2.2.2. MARKET VOLUME(UNITS)

9.2.1.3.2.2.3. AVEARGE SELLING PRICE(ASP)

9.2.1.3.3. FLUORIDE OXALATE

9.2.1.3.3.1 PLASTIC

9.2.1.3.3.1.1. MARKET VALUE (USD MILLION)

9.2.1.3.3.1.2. MARKET VOLUME(UNITS)

9.2.1.3.3.1.3. AVEARGE SELLING PRICE(ASP)

9.2.1.3.3.2 GLASS

9.2.1.3.3.2.1. MARKET VALUE (USD MILLION)

9.2.1.3.3.2.2. MARKET VOLUME(UNITS)

9.2.1.3.3.2.3. AVEARGE SELLING PRICE(ASP)

9.2.1.3.4. OTHERS

9.2.1.4. ERYTHROCYTE SEDIMENTATION RATE (ESR) TUBES

9.2.1.4.1. PLASTIC

9.2.1.4.1.1 MARKET VALUE (USD MILLION)

9.2.1.4.1.2 MARKET VOLUME(UNITS)

9.2.1.4.1.3 AVEARGE SELLING PRICE(ASP)

9.2.1.4.2. GLASS

9.2.1.4.2.1 MARKET VALUE (USD MILLION)

9.2.1.4.2.2 MARKET VOLUME(UNITS)

9.2.1.4.2.3 AVEARGE SELLING PRICE(ASP)

9.2.1.5. SERUM-SEPARATING TUBES

9.2.1.5.1. GLASS

9.2.1.5.1.1 MARKET VALUE (USD MILLION)

9.2.1.5.1.2 MARKET VOLUME(UNITS)

9.2.1.5.1.3 AVEARGE SELLING PRICE(ASP)

9.2.1.5.2. PLASTIC

9.2.1.5.2.1 MARKET VALUE (USD MILLION)

9.2.1.5.2.2 MARKET VOLUME(UNITS)

9.2.1.5.2.3 AVEARGE SELLING PRICE(ASP)

9.2.1.6. RAPID SERUM TUBES

9.2.1.6.1. MARKET VALUE (USD MILLION)

9.2.1.6.2. MARKET VOLUME(UNITS)

9.2.1.6.3. AVEARGE SELLING PRICE(ASP)

9.2.1.7. EDTA TUBES

9.2.1.7.1. MARKET VALUE (USD MILLION)

9.2.1.7.2. MARKET VOLUME(UNITS)

9.2.1.7.3. AVEARGE SELLING PRICE(ASP)

9.2.1.8. OTHERS

9.2.2 BLOOD BAGS

9.2.2.1. SINGLE BLOOD BAG

9.2.2.1.1. 0 ML – 100 ML

9.2.2.1.1.1 MARKET VALUE (USD MILLION)

9.2.2.1.1.2 MARKET VOLUME(UNITS)

9.2.2.1.1.3 AVEARGE SELLING PRICE(ASP)

9.2.2.1.2. 100 ML – 250 ML

9.2.2.1.2.1 MARKET VALUE (USD MILLION)

9.2.2.1.2.2 MARKET VOLUME(UNITS)

9.2.2.1.2.3 AVEARGE SELLING PRICE(ASP)

 

9.2.2.1.3. 250 ML -450 ML

9.2.2.1.3.1 MARKET VALUE (USD MILLION)

9.2.2.1.3.2 MARKET VOLUME(UNITS)

9.2.2.1.3.3 AVEARGE SELLING PRICE(ASP)

9.2.2.1.4. 450 ML – 700 ML

9.2.2.1.4.1 MARKET VALUE (USD MILLION)

9.2.2.1.4.2 MARKET VOLUME(UNITS)

9.2.2.1.4.3 AVEARGE SELLING PRICE(ASP)

9.2.2.1.5. 700 ML – 1000 ML

9.2.2.1.5.1 MARKET VALUE (USD MILLION)

9.2.2.1.5.2 MARKET VOLUME(UNITS)

9.2.2.1.5.3 AVEARGE SELLING PRICE(ASP)

9.2.2.1.6. OTHERS

9.2.2.2. DOUBLE BLOOD BAG

9.2.2.2.1. 0 ML – 100 ML

9.2.2.2.1.1 MARKET VALUE (USD MILLION)

9.2.2.2.1.2 MARKET VOLUME(UNITS)

9.2.2.2.1.3 AVEARGE SELLING PRICE(ASP)

9.2.2.2.2. 100 ML – 250 ML

9.2.2.2.2.1 MARKET VALUE (USD MILLION)

9.2.2.2.2.2 MARKET VOLUME(UNITS)

9.2.2.2.2.3 AVEARGE SELLING PRICE(ASP)

9.2.2.2.3. 250 ML -450 ML

9.2.2.2.3.1 MARKET VALUE (USD MILLION)

9.2.2.2.3.2 MARKET VOLUME(UNITS)

9.2.2.2.3.3 AVEARGE SELLING PRICE(ASP)

9.2.2.2.4. 450 ML – 700 ML

9.2.2.2.4.1 MARKET VALUE (USD MILLION)

9.2.2.2.4.2 MARKET VOLUME(UNITS)

9.2.2.2.4.3 AVEARGE SELLING PRICE(ASP)

9.2.2.2.5. 700 ML – 1000 ML

9.2.2.2.5.1 MARKET VALUE (USD MILLION)

9.2.2.2.5.2 MARKET VOLUME(UNITS)

9.2.2.2.5.3 AVEARGE SELLING PRICE(ASP)

9.2.2.2.6. OTHERS

 

9.2.2.3. TRIPLE BLOOD BAG

9.2.2.3.1. 0 ML – 100 ML

9.2.2.3.1.1 MARKET VALUE (USD MILLION)

9.2.2.3.1.2 MARKET VOLUME(UNITS)

9.2.2.3.1.3 AVEARGE SELLING PRICE(ASP)

9.2.2.3.2. 100 ML – 250 ML

9.2.2.3.2.1 MARKET VALUE (USD MILLION)

9.2.2.3.2.2 MARKET VOLUME(UNITS)

9.2.2.3.2.3 AVEARGE SELLING PRICE(ASP)

9.2.2.3.3. 250 ML -450 ML

9.2.2.3.3.1 MARKET VALUE (USD MILLION)

9.2.2.3.3.2 MARKET VOLUME(UNITS)

9.2.2.3.3.3 AVEARGE SELLING PRICE(ASP)

9.2.2.3.4. 450 ML – 700 ML

9.2.2.3.4.1 MARKET VALUE (USD MILLION)

9.2.2.3.4.2 MARKET VOLUME(UNITS)

9.2.2.3.4.3 AVEARGE SELLING PRICE(ASP)

9.2.2.3.5. 700 ML – 1000 ML

9.2.2.3.5.1 MARKET VALUE (USD MILLION)

9.2.2.3.5.2 MARKET VOLUME(UNITS)

9.2.2.3.5.3 AVEARGE SELLING PRICE(ASP)

9.2.2.4. OTHERS

9.2.3 CAPILLARY

9.2.3.1. REMOTE CAPILLARY BLOOD COLLECTION DEVICE

9.2.3.1.1. COLLECTION KITS

9.2.3.1.1.1 10 µL

9.2.3.1.1.1.1. MARKET VALUE (USD MILLION)

9.2.3.1.1.1.2. MARKET VOLUME(UNITS)

9.2.3.1.1.1.3. AVEARGE SELLING PRICE(ASP)

9.2.3.1.1.2 20 µL

9.2.3.1.1.2.1. MARKET VALUE (USD MILLION)

9.2.3.1.1.2.2. MARKET VOLUME(UNITS)

9.2.3.1.1.2.3. AVEARGE SELLING PRICE(ASP)

9.2.3.1.1.3 30 µL

9.2.3.1.1.3.1. MARKET VALUE (USD MILLION)

9.2.3.1.1.3.2. MARKET VOLUME(UNITS)

9.2.3.1.1.3.3. AVEARGE SELLING PRICE(ASP)

 

9.2.3.1.2. CARTRIDGE

9.2.3.1.2.1 MARKET VALUE (USD MILLION)

9.2.3.1.2.2 MARKET VOLUME(UNITS)

9.2.3.1.2.3 AVEARGE SELLING PRICE(ASP)

9.2.3.1.3. CLAMSHELL

9.2.3.1.3.1 MARKET VALUE (USD MILLION)

9.2.3.1.3.2 MARKET VOLUME(UNITS)

9.2.3.1.3.3 AVEARGE SELLING PRICE(ASP)

9.2.3.1.4. AUTORACK

9.2.3.1.4.1 MARKET VALUE (USD MILLION)

9.2.3.1.4.2 MARKET VOLUME(UNITS)

9.2.3.1.4.3 AVEARGE SELLING PRICE(ASP)

9.2.3.2. RAPID TEST CASSETTE

9.2.3.2.1. MARKET VALUE (USD MILLION)

9.2.3.2.2. MARKET VOLUME(UNITS)

9.2.3.2.3. AVEARGE SELLING PRICE(ASP)

9.2.3.3. WEARABLE CAPILLARY BLOOD COLLECTION DEVICE

9.2.3.3.1. MARKET VALUE (USD MILLION)

9.2.3.3.2. MARKET VOLUME(UNITS)

9.2.3.3.3. AVEARGE SELLING PRICE(ASP)

9.2.3.4. AUTO-INJECTION BASED DEVICES

9.2.3.4.1. PEDIATRIC

9.2.3.4.1.1 MARKET VALUE (USD MILLION)

9.2.3.4.1.2 MARKET VOLUME(UNITS)

9.2.3.4.1.3 AVEARGE SELLING PRICE(ASP)

9.2.3.4.2. ADULT BASED

9.2.3.4.2.1 MARKET VALUE (USD MILLION)

9.2.3.4.2.2 MARKET VOLUME(UNITS)

9.2.3.4.2.3 AVEARGE SELLING PRICE(ASP)

9.2.3.5. CAPILLARY BLOOD COLLECTION DEVICES

9.2.3.5.1. LANCETS

9.2.3.5.1.1 SAFETY LANCETS

9.2.3.5.1.1.1. MARKET VALUE (USD MILLION)

9.2.3.5.1.1.2. MARKET VOLUME(UNITS)

9.2.3.5.1.1.3. AVEARGE SELLING PRICE(ASP)

 

9.2.3.5.1.2 LASER LANCET

9.2.3.5.1.2.1. MARKET VALUE (USD MILLION)

9.2.3.5.1.2.2. MARKET VOLUME(UNITS)

9.2.3.5.1.2.3. AVEARGE SELLING PRICE(ASP)

9.2.3.5.1.3 HEEL PUNCTURE LANCETS

9.2.3.5.1.3.1. MARKET VALUE (USD MILLION)

9.2.3.5.1.3.2. MARKET VOLUME(UNITS)

9.2.3.5.1.3.3. AVEARGE SELLING PRICE(ASP)

9.2.3.5.1.4 CONTACT-ACTIVATED LANCET

9.2.3.5.1.4.1. MARKET VALUE (USD MILLION)

9.2.3.5.1.4.2. MARKET VOLUME(UNITS)

9.2.3.5.1.4.3. AVEARGE SELLING PRICE(ASP)

9.2.3.5.1.5 HOMECARE LANCETS

9.2.3.5.1.5.1. MARKET VALUE (USD MILLION)

9.2.3.5.1.5.2. MARKET VOLUME(UNITS)

9.2.3.5.1.5.3. AVEARGE SELLING PRICE(ASP)

9.2.3.5.1.6 OTHERS

9.2.3.5.2. MICRO-HEMATOCRIT TUBES

9.2.3.5.2.1 HEPARINIZED

9.2.3.5.2.1.1. MARKET VALUE (USD MILLION)

9.2.3.5.2.1.2. MARKET VOLUME(UNITS)

9.2.3.5.2.1.3. AVEARGE SELLING PRICE(ASP)

9.2.3.5.2.2 NON- HEPARINIZED

9.2.3.5.2.2.1. MARKET VALUE (USD MILLION)

9.2.3.5.2.2.2. MARKET VOLUME(UNITS)

9.2.3.5.2.2.3. AVEARGE SELLING PRICE(ASP)

9.2.3.5.3. WARMING DEVICES

9.2.3.5.3.1 MARKET VALUE (USD MILLION)

9.2.3.5.3.2 MARKET VOLUME(UNITS)

9.2.3.5.3.3 AVEARGE SELLING PRICE(ASP)

9.2.3.6. OTHERS

9.2.4 BLOOD COLLECTION DEVICES

9.2.4.1. MANUAL BLOOD COLLECTION

9.2.4.2. AUTOMATED BLOOD COLLECTION

9.2.5 VIALS

9.2.5.1. MARKET VALUE (USD MILLION)

9.2.5.2. MARKET VOLUME(UNITS)

9.2.5.3. AVEARGE SELLING PRICE(ASP)

9.3 SWABS COLLECTION KITS

9.3.1 BY TYPES

9.3.1.1. NARES

9.3.1.2. OROPHARYNGEAL

9.3.1.3. NASOPHARYNGEAL

9.3.2 BY CONFIGURATION

9.3.2.1. REGULAR SWAB

9.3.2.2. FLOCKED SWAB

9.3.2.3. OTHERS

9.3.3 BY TIP MATERIALS

9.3.3.1. POLYESTER

9.3.3.2. NYLON

9.3.3.3. CALCIUM ALGINATE

9.3.3.4. COTTON

9.3.3.5. RAYON

9.3.3.6. FOAM

9.3.3.7. OTHERS

9.3.4 BY SHAFT

9.3.4.1. PLASTIC SHAFTS

9.3.4.2. WOODEN SHAFTS

9.3.4.3. RESINS

9.3.4.4. ALUMINUM

9.3.4.5. OTHERS

9.4 URINE COLLECTION KITS

9.4.1 BY PRODUCT

9.4.1.1. URINARY SAMPLE SYSTEM

9.4.1.1.1. CONTAINERS

9.4.1.1.1.1 MARKET VALUE (USD MILLION)

9.4.1.1.1.2 MARKET VOLUME(UNITS)

9.4.1.1.1.3 AVEARGE SELLING PRICE(ASP)

9.4.1.1.2. CUPS

9.4.1.1.2.1 MARKET VALUE (USD MILLION)

9.4.1.1.2.2 MARKET VOLUME(UNITS)

9.4.1.1.2.3 AVEARGE SELLING PRICE(ASP)

9.4.1.1.3. URINALYSIS TUBES

9.4.1.1.3.1 MARKET VALUE (USD MILLION)

9.4.1.1.3.2 MARKET VOLUME(UNITS)

9.4.1.1.3.3 AVEARGE SELLING PRICE(ASP)

 

9.4.1.2. URINARY CATHETER

9.4.1.2.1. INDWELLING CATHETER

9.4.1.2.1.1 FOLEY CATHETER

9.4.1.2.1.1.1. MARKET VALUE (USD MILLION)

9.4.1.2.1.1.2. MARKET VOLUME(UNITS)

9.4.1.2.1.1.3. AVEARGE SELLING PRICE(ASP)

9.4.1.2.1.2 SUPRAPUBIC CATHETER

9.4.1.2.1.2.1. MARKET VALUE (USD MILLION)

9.4.1.2.1.2.2. MARKET VOLUME(UNITS)

9.4.1.2.1.2.3. AVEARGE SELLING PRICE(ASP)

9.4.1.2.2. INTERMITTENT CATHETER

9.4.1.2.2.1 MARKET VALUE (USD MILLION)

9.4.1.2.2.2 MARKET VOLUME(UNITS)

9.4.1.2.2.3 AVEARGE SELLING PRICE(ASP)

9.4.1.2.3. EXTERNAL CATHETER

9.4.1.2.3.1 MARKET VALUE (USD MILLION)

9.4.1.2.3.2 MARKET VOLUME(UNITS)

9.4.1.2.3.3 AVEARGE SELLING PRICE(ASP)

9.4.1.3. URINE BAGS

9.4.1.3.1. URINARY LEG BAGS

9.4.1.3.1.1 MARKET VALUE (USD MILLION)

9.4.1.3.1.2 MARKET VOLUME(UNITS)

9.4.1.3.1.3 AVEARGE SELLING PRICE(ASP)

9.4.1.3.2. URINARY DRAINAGE BAGS

9.4.1.3.2.1 MARKET VALUE (USD MILLION)

9.4.1.3.2.2 MARKET VOLUME(UNITS)

9.4.1.3.2.3 AVEARGE SELLING PRICE(ASP)

9.4.1.3.3. URINARY BELLY BAGS

9.4.1.3.3.1 MARKET VALUE (USD MILLION)

9.4.1.3.3.2 MARKET VOLUME(UNITS)

9.4.1.3.3.3 AVEARGE SELLING PRICE(ASP)

9.4.1.4. ACCESSORIES

9.4.1.4.1. MARKET VALUE (USD MILLION)

9.4.1.4.2. MARKET VOLUME(UNITS)

9.4.1.4.3. AVEARGE SELLING PRICE(ASP)

 

9.4.2 BY MATERIAL

9.4.2.1. SILICON

9.4.2.1.1. MARKET VALUE (USD MILLION)

9.4.2.1.2. MARKET VOLUME(UNITS)

9.4.2.1.3. AVEARGE SELLING PRICE(ASP)

9.4.2.2. LATEX

9.4.2.2.1. MARKET VALUE (USD MILLION)

9.4.2.2.2. MARKET VOLUME(UNITS)

9.4.2.2.3. AVEARGE SELLING PRICE(ASP)

9.4.2.3. RUBBER

9.4.2.3.1. MARKET VALUE (USD MILLION)

9.4.2.3.2. MARKET VOLUME(UNITS)

9.4.2.3.3. AVEARGE SELLING PRICE(ASP)

9.4.2.4. OTHERS

9.5 FLUID COLLECTION KITS

9.5.1 CEREBROSPINAL FLUID (CSF) TUBES

9.5.1.1. MARKET VALUE (USD MILLION)

9.5.1.2. MARKET VOLUME(UNITS)

9.5.1.3. AVEARGE SELLING PRICE(ASP)

9.5.2 AMNIOTIC FLUID TUBES

9.5.2.1. MARKET VALUE (USD MILLION)

9.5.2.2. MARKET VOLUME(UNITS)

9.5.2.3. AVEARGE SELLING PRICE(ASP)

9.5.3 OTHERS

9.6 SEMEN COLLECTION KITS

9.6.1 NON-SPERMICIDAL POLYURETHANE CONDOM

9.6.1.1. MARKET VALUE (USD MILLION)

9.6.1.2. MARKET VOLUME(UNITS)

9.6.1.3. AVEARGE SELLING PRICE(ASP)

9.6.2 VIALS

9.6.2.1. MARKET VALUE (USD MILLION)

9.6.2.2. MARKET VOLUME(UNITS)

9.6.2.3. AVEARGE SELLING PRICE(ASP)

9.6.3 OTHERS

9.7 STOOL COLLECTION KITS

9.8 VIRAL TRANSPORT MEDIA

9.9 OTHERS

 

10 GLOBAL SPECIMEN COLLECTION MARKET, BY MODALITY

10.1 OVERVIEW

10.2 MANUAL

10.3 AUTOMATED

11 GLOBAL SPECIMEN COLLECTION KIT MARKET , BY APPLICATION

11.1 OVERVIEW

11.2 DIAGNOSTICS

11.2.1 INFECTIOUS DISEASES

11.2.2 NON-INFECTIOUS DISEASES

11.2.3 OTHERS

11.3 RESEARCH

11.4 OTHER

12 GLOBAL SPECIMEN COLLECTION KIT MARKET, BY AGE

12.1 OVERVIEW

12.2 PEDIATRIC

12.3 ADULTS

12.4 GERIATRICS

13 GLOBAL SPECIMEN COLLECTION KIT MARKET, BY GENDER

13.1 OVERVIEW

13.2 MALE

13.3 FEMALE

14 GLOBAL SPECIMEN COLLECTION KIT MARKET, BY SITE OF COLLECTION

14.1 OVERVIEW

14.2 HOME BASED COLLECTION

14.3 LABORATORIES BASED COLLECTION

 

15 GLOBAL SPECIMEN COLLECTION KIT MARKET, BY END USER

15.1 OVERVIEW

15.2 HOSPITALS

15.2.1 GOVERNMENT

15.2.1.1. MILITARY HOSPITAL

15.2.1.2. PUBLIC HOSPITAL

15.2.1.2.1. 100 BED HOSPITAL

15.2.1.2.2. 100-200 BED HOSPITAL

15.2.1.2.3. ABOVE BED HOSPITAL

15.2.2 PRIVATE

15.2.2.1. 100 BED HOSPITAL

15.2.2.2. 100-200 BED HOSPITAL

15.2.2.3. ABOVE BED HOSPITAL

15.3 CLINICS

15.4 DIAGNOSTIC LABORATORIES

15.4.1 PATHOLOGY

15.4.1.1. GOVERNMENT

15.4.1.2. PRIVATE

15.4.2 LAB CHAINS

15.4.2.1. GOVERNMENT

15.4.2.2. PRIVATE

15.4.3 REFERRAL LABS

15.4.3.1. GOVERNMENT

15.4.3.2. PRIVATE

15.4.4 OTHERS

15.5 BLOOD BANKS

15.6 RESEARCH INSTITUTIONS & ACADEMIC

15.7 HOME HEALTHCARE

15.8 OTHERS

16 GLOBAL SPECIMEN COLLECTION KIT MARKET , BY DISTRIBUTION CHANNEL

16.1 OVERVIEW

16.2 DIRECT TENDER

16.3 RETAIL SALES

16.4 OTHERS

 

17 GLOBAL SPECIMEN COLLECTION KIT MARKET , COMPANY LANDSCAPE

17.1 COMPANY SHARE ANALYSIS: GLOBAL

17.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

17.3 COMPANY SHARE ANALYSIS: EUROPE

17.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

17.5 MERGERS & ACQUISITIONS

17.6 NEW PRODUCT DEVELOPMENT & APPROVALS

17.7 EXPANSIONS

17.8 REGULATORY CHANGES

17.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

18 GLOBAL SPECIMEN COLLECTION KIT MARKET , BY GEOGRAPHY

GLOBAL SPECIMEN COLLECTION KIT MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

18.1 NORTH AMERICA

18.1.1 U.S.

18.1.2 CANADA

18.1.3 MEXICO

18.2 EUROPE

18.2.1 GERMANY

18.2.2 FRANCE

18.2.3 U.K.

18.2.4 HUNGARY

18.2.5 LITHUANIA

18.2.6 AUSTRIA

18.2.7 IRELAND

18.2.8 NORWAY

18.2.9 POLAND

18.2.10 ITALY

18.2.11 SPAIN

18.2.12 RUSSIA

18.2.13 TURKEY

18.2.14 NETHERLANDS

18.2.15 SWITZERLAND

18.2.16 REST OF EUROPE

 

18.3 ASIA-PACIFIC

18.3.1 JAPAN

18.3.2 CHINA

18.3.3 SOUTH KOREA

18.3.4 INDIA

18.3.5 SINGAPORE

18.3.6 THAILAND

18.3.7 INDONESIA

18.3.8 MALAYSIA

18.3.9 PHILIPPINES

18.3.10 AUSTRALIA

18.3.11 NEW ZEALAND

18.3.12 VIETNAM

18.3.13 TAIWAN

18.3.14 REST OF ASIA-PACIFIC REST OF ASIA-PACIFIC

18.4 SOUTH AMERICA

18.4.1 BRAZIL

18.4.2 ARGENTINA

18.4.3 REST OF SOUTH AMERICA

18.5 MIDDLE EAST AND AFRICA

18.5.1 SOUTH AFRICA

18.5.2 EGYPT

18.5.3 BAHRAIN

18.5.4 UNITED ARAB EMIRATES

18.5.5 KUWAIT

18.5.6 OMAN

18.5.7 QATAR

18.5.8 SAUDI ARABIA

18.5.9 REST OF MIDDLE EAST AND AFRICA

18.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

19 GLOBAL SPECIMEN COLLECTION KIT MARKET , SWOT AND DBMR ANALYSIS

20 GLOBAL SPECIMEN COLLECTION KIT MARKET , COMPANY PROFILE

20.1 ABBOTT

20.1.1 COMPANY OVERVIEW

20.1.2 REVENUE ANALYSIS

20.1.3 GEOGRAPHIC PRESENCE

20.1.4 PRODUCT PORTFOLIO

20.1.5 RECENT DEVELOPMENTS

 

20.2 BD

20.2.1 COMPANY OVERVIEW

20.2.2 REVENUE ANALYSIS

20.2.3 GEOGRAPHIC PRESENCE

20.2.4 PRODUCT PORTFOLIO

20.2.5 RECENT DEVELOPMENTS

20.3 THERMO FISHER SCIENTIFIC INC.

20.3.1 COMPANY OVERVIEW

20.3.2 REVENUE ANALYSIS

20.3.3 GEOGRAPHIC PRESENCE

20.3.4 PRODUCT PORTFOLIO

20.3.5 RECENT DEVELOPMENTS

20.4 F. HOFFMANN-LA ROCHE LTD

20.4.1 COMPANY OVERVIEW

20.4.2 REVENUE ANALYSIS

20.4.3 GEOGRAPHIC PRESENCE

20.4.4 PRODUCT PORTFOLIO

20.4.5 RECENT DEVELOPMENTS

20.5 B. BRAUN SE

20.5.1 COMPANY OVERVIEW

20.5.2 REVENUE ANALYSIS

20.5.3 GEOGRAPHIC PRESENCE

20.5.4 PRODUCT PORTFOLIO

20.5.5 RECENT DEVELOPMENTS

20.6 QUIDEL CORPORATION

20.6.1 COMPANY OVERVIEW

20.6.2 REVENUE ANALYSIS

20.6.3 GEOGRAPHIC PRESENCE

20.6.4 PRODUCT PORTFOLIO

20.6.5 RECENT DEVELOPMENTS

20.7 SMITHS MEDICAL

20.7.1 COMPANY OVERVIEW

20.7.2 REVENUE ANALYSIS

20.7.3 GEOGRAPHIC PRESENCE

20.7.4 PRODUCT PORTFOLIO

20.7.5 RECENT DEVELOPMENTS

 

20.8 BIOMÉRIEUX SA

20.8.1 COMPANY OVERVIEW

20.8.2 REVENUE ANALYSIS

20.8.3 GEOGRAPHIC PRESENCE

20.8.4 PRODUCT PORTFOLIO

20.8.5 RECENT DEVELOPMENTS

20.9 CARDINAL HEALTH.

20.9.1 COMPANY OVERVIEW

20.9.2 REVENUE ANALYSIS

20.9.3 GEOGRAPHIC PRESENCE

20.9.4 PRODUCT PORTFOLIO

20.9.5 RECENT DEVELOPMENTS

20.1 BIO-RAD LABORATORIES, INC.

20.10.1 COMPANY OVERVIEW

20.10.2 REVENUE ANALYSIS

20.10.3 GEOGRAPHIC PRESENCE

20.10.4 PRODUCT PORTFOLIO

20.10.5 RECENT DEVELOPMENTS

20.11 TRINITY BIOTECH

20.11.1 COMPANY OVERVIEW

20.11.2 REVENUE ANALYSIS

20.11.3 GEOGRAPHIC PRESENCE

20.11.4 PRODUCT PORTFOLIO

20.11.5 RECENT DEVELOPMENTS

20.12 GERRESHEIMER AG

20.12.1 COMPANY OVERVIEW

20.12.2 REVENUE ANALYSIS

20.12.3 GEOGRAPHIC PRESENCE

20.12.4 PRODUCT PORTFOLIO

20.12.5 RECENT DEVELOPMENTS

20.13 QIAGEN

20.13.1 COMPANY OVERVIEW

20.13.2 REVENUE ANALYSIS

20.13.3 GEOGRAPHIC PRESENCE

20.13.4 PRODUCT PORTFOLIO

20.13.5 RECENT DEVELOPMENTS

 

20.14 NORGEN BIOTEK CORP.

20.14.1 COMPANY OVERVIEW

20.14.2 REVENUE ANALYSIS

20.14.3 GEOGRAPHIC PRESENCE

20.14.4 PRODUCT PORTFOLIO

20.14.5 RECENT DEVELOPMENTS

20.15 MEDTRONIC

20.15.1 COMPANY OVERVIEW

20.15.2 REVENUE ANALYSIS

20.15.3 GEOGRAPHIC PRESENCE

20.15.4 PRODUCT PORTFOLIO

20.15.5 RECENT DEVELOPMENTS

20.16 GRIFOLS, S.A

20.16.1 COMPANY OVERVIEW

20.16.2 REVENUE ANALYSIS

20.16.3 GEOGRAPHIC PRESENCE

20.16.4 PRODUCT PORTFOLIO

20.16.5 RECENT DEVELOPMENTS

20.17 GOLDWIN MEDICARE

20.17.1 COMPANY OVERVIEW

20.17.2 REVENUE ANALYSIS

20.17.3 GEOGRAPHIC PRESENCE

20.17.4 PRODUCT PORTFOLIO

20.17.5 RECENT DEVELOPMENTS

20.18 EVERLYWELL, INC

20.18.1 COMPANY OVERVIEW

20.18.2 REVENUE ANALYSIS

20.18.3 GEOGRAPHIC PRESENCE

20.18.4 PRODUCT PORTFOLIO

20.18.5 RECENT DEVELOPMENTS

20.19 COPAN DIAGNOSTICS INC

20.19.1 COMPANY OVERVIEW

20.19.2 REVENUE ANALYSIS

20.19.3 GEOGRAPHIC PRESENCE

20.19.4 PRODUCT PORTFOLIO

20.19.5 RECENT DEVELOPMENTS

 

20.2 QUEST DIAGNOSTICS

20.20.1 COMPANY OVERVIEW

20.20.2 REVENUE ANALYSIS

20.20.3 GEOGRAPHIC PRESENCE

20.20.4 PRODUCT PORTFOLIO

20.20.5 RECENT DEVELOPMENTS

20.21 HOLOGIC, INC.

20.21.1 COMPANY OVERVIEW

20.21.2 REVENUE ANALYSIS

20.21.3 GEOGRAPHIC PRESENCE

20.21.4 PRODUCT PORTFOLIO

20.21.5 RECENT DEVELOPMENTS

20.22 GENEDX, LLC

20.22.1 COMPANY OVERVIEW

20.22.2 REVENUE ANALYSIS

20.22.3 GEOGRAPHIC PRESENCE

20.22.4 PRODUCT PORTFOLIO

20.22.5 RECENT DEVELOPMENTS

20.23 TITAN BIOTECH LIMITED

20.23.1 COMPANY OVERVIEW

20.23.2 REVENUE ANALYSIS

20.23.3 GEOGRAPHIC PRESENCE

20.23.4 PRODUCT PORTFOLIO

20.23.5 RECENT DEVELOPMENTS

20.24 PURITAN MEDICAL PRODUCTS

20.24.1 COMPANY OVERVIEW

20.24.2 REVENUE ANALYSIS

20.24.3 GEOGRAPHIC PRESENCE

20.24.4 PRODUCT PORTFOLIO

20.24.5 RECENT DEVELOPMENTS

20.25 PATH-TEC, LLC

20.25.1 COMPANY OVERVIEW

20.25.2 REVENUE ANALYSIS

20.25.3 GEOGRAPHIC PRESENCE

20.25.4 PRODUCT PORTFOLIO

20.25.5 RECENT DEVELOPMENTS

 

20.26 LUCENCE HEALTH INC.

20.26.1 COMPANY OVERVIEW

20.26.2 REVENUE ANALYSIS

20.26.3 GEOGRAPHIC PRESENCE

20.26.4 PRODUCT PORTFOLIO

20.26.5 RECENT DEVELOPMENTS

20.27 HARDY DIAGNOSTICS

20.27.1 COMPANY OVERVIEW

20.27.2 REVENUE ANALYSIS

20.27.3 GEOGRAPHIC PRESENCE

20.27.4 PRODUCT PORTFOLIO

20.27.5 RECENT DEVELOPMENTS

20.28 HIMEDIA LABORATORIES

20.28.1 COMPANY OVERVIEW

20.28.2 REVENUE ANALYSIS

20.28.3 GEOGRAPHIC PRESENCE

20.28.4 PRODUCT PORTFOLIO

20.28.5 RECENT DEVELOPMENTS

20.29 MEDLINE INDUSTRIES, LP

20.29.1 COMPANY OVERVIEW

20.29.2 REVENUE ANALYSIS

20.29.3 GEOGRAPHIC PRESENCE

20.29.4 PRODUCT PORTFOLIO

20.29.5 RECENT DEVELOPMENTS

20.3 BTNX INC.

20.30.1 COMPANY OVERVIEW

20.30.2 REVENUE ANALYSIS

20.30.3 GEOGRAPHIC PRESENCE

20.30.4 PRODUCT PORTFOLIO

20.30.5 RECENT DEVELOPMENTS

20.31 DIASORIN MOLECULAR LLC.

20.31.1 COMPANY OVERVIEW

20.31.2 REVENUE ANALYSIS

20.31.3 GEOGRAPHIC PRESENCE

20.31.4 PRODUCT PORTFOLIO

20.31.5 RECENT DEVELOPMENTS

 

20.32 MEDICAL WIRE & EQUIPMENT

20.32.1 COMPANY OVERVIEW

20.32.2 REVENUE ANALYSIS

20.32.3 GEOGRAPHIC PRESENCE

20.32.4 PRODUCT PORTFOLIO

20.32.5 RECENT DEVELOPMENTS

20.33 MIRACLEAN TECHNOLOGY CO.,LTD.

20.33.1 COMPANY OVERVIEW

20.33.2 REVENUE ANALYSIS

20.33.3 GEOGRAPHIC PRESENCE

20.33.4 PRODUCT PORTFOLIO

20.33.5 RECENT DEVELOPMENTS

NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST

21 RELATED REPORTS

22 CONCLUSION

23 QUESTIONNAIRE

24 ABOUT DATA BRIDGE MARKET RESEARCH